Arteriosclerosis, Thrombosis, Vascular Biology
Science NewsView All Science News
11/16/2019 | Science News coverage of selected presentations and interviews from AHA's Scientific Sessions 2019. Nov. 16-18, 2019 in Philadelphia, PA.
11/11/2019 | CIRCULATION RESEARCH Featured articles for November 2019
11/07/2019 | Subclinical AF (SCAF) is associated with at least a two-fold increased risk of stroke and almost six-fold increased risk of progressing t...
10/29/2019 | ATVB Twitter Chat September 2019 issue
Vascular Discovery: From Genes to Medicine 2019
May 14–16, 2019
Boston, Massachusetts
Related Councils
Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)
The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
Mary Sorci-Thomas, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology
Council on Peripheral Vascular Disease (PVD)
The Council on Peripheral Vascular Disease (PVD) is a vibrant, interdisciplinary council whose members are focused on improving the care of patients with vascular diseases through advancing science, education, advocacy, and improved healthcare delivery. To achieve our goals within the American Heart Association we need to continue to grow our membership and foster their active involvement in all of our educational programs and scientific initiatives. This means we need you!
Naomi Hamburg, MD, MS, FAHA
Chair, Council on Peripheral Vascular Disease
Podcast series on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D) with cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making — among other topics. Listen today and improve your patient’s outcomes!
Finding time to move during the work day can be a challenge. Take a midday walk or try our tips to add movement in your day. #HealthyforGood